+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

MeMed Diagnostics LTD - Product Pipeline Analysis, 2021 Update

  • ID: 5367373
  • Company Profile
  • June 2021
  • 37 pages
  • GlobalData

FEATURED COMPANIES

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

MeMed Diagnostics Ltd (MeMed) is a developer of diagnostic solutions for inflammatory and infectious diseases. The company’s products include ImmunoXpert, which is an in-vitro diagnostic test used for diagnosing the difference between bacterial and viral infections. It provides ImmunoPoC, a hand-held instrument used for the diagnosis of bacterial versus viral infections. MeMed offers services in varied fields including molecular immunology, clinical infectious diseases, informatics and in vitro diagnostics. The company uses its technology to discover, develop and validate novel diagnostic solutions. It partners with various academic, clinical and commercial partners. It operates through its manufacturing and research and development facilities in Isreal. MeMed is headquartered in Tirat Carmel, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MeMed Diagnostics LTD
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

MeMed Diagnostics LTD Company Overview
  • MeMed Diagnostics LTD Company Snapshot
  • MeMed Diagnostics LTD Pipeline Products and Ongoing Clinical Trials Overview
  • MeMed Diagnostics LTD - Pipeline Analysis Overview
  • MeMed Diagnostics LTD - Key Facts
  • MeMed Diagnostics LTD - Major Products and Services
  • MeMed Diagnostics LTD Pipeline Products by Development Stage
  • MeMed Diagnostics LTD Ongoing Clinical Trials by Trial Status
MeMed Diagnostics LTD Pipeline Products Overview
  • Diagnostic Test - COVID-19
  • Diagnostic Test - COVID-19 Product Overview
  • ImmunoPoC
  • ImmunoPoC Product Overview
  • MeMed Alert
  • MeMed Alert Product Overview
  • MeMed BV
  • MeMed BV Product Overview
  • MeMed BV Clinical Trial
  • MeMed COVID-19 Severity Test
  • MeMed COVID-19 Severity Test Product Overview
  • MeMed ImmnuoRNA
  • MeMed ImmnuoRNA Product Overview
  • MeMed Neo
  • MeMed Neo Product Overview
  • MeMed Sepsis
  • MeMed Sepsis Product Overview
  • MeMed Ultra Flu
  • MeMed Ultra Flu Product Overview
  • Prognostic Test - COVID-19
  • Prognostic Test - COVID-19 Product Overview
MeMed Diagnostics LTD - Key Competitors

MeMed Diagnostics LTD - Key Employees

MeMed Diagnostics LTD - Locations and Subsidiaries
  • Head Office
Recent Developments
  • MeMed Diagnostics LTD, Recent Developments
  • Nov 13, 2019: MeMed wins €2.5M Award from European Innovation Council
  • Oct 29, 2019: Diagnostics Industry Veteran Dr. Frederic Sweeney joins MeMed as Chief Business Development Officer
  • Oct 29, 2019: Diagnostics industry veteran Dr. Frederic Sweeney joins MeMed as chief business development officer
  • Dec 05, 2018: DTRA commits additional funds to MeMed''s innovative bacterial versus viral test and point-of-care platform
  • Sep 24, 2018: MeMed raises funds to support diagnostics development
  • May 15, 2018: New Study Demonstrates Superiority of MeMed''s ImmunoXpert Over Procalcitonin, CRP, HNL and Additional Biomarkers in Distinguishing Bacterial From Viral Infections
  • Feb 06, 2018: MeMed secures additional funding from the Department of Defense
  • Sep 18, 2017: MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish Between Bacterial and Viral Infections
  • Apr 19, 2017: MeMed Awarded $9.2M Contract by US Department of Defense
  • Dec 21, 2016: Lancet Infectious Diseases Publishes Independent Double-Blind Study Validating MeMed's Immunoxpert Blood Test's Ability to Accurately Distinguish Between Bacterial and Viral Infections in Children
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • MeMed Diagnostics LTD Pipeline Products and Ongoing Clinical Trials Overview
  • MeMed Diagnostics LTD Pipeline Products by Equipment Type
  • MeMed Diagnostics LTD Pipeline Products by Indication
  • MeMed Diagnostics LTD Ongoing Clinical Trials by Trial Status
  • MeMed Diagnostics LTD, Key Facts
  • MeMed Diagnostics LTD, Major Products and Services
  • MeMed Diagnostics LTD Number of Pipeline Products by Development Stage
  • MeMed Diagnostics LTD Pipeline Products Summary by Development Stage
  • MeMed Diagnostics LTD Ongoing Clinical Trials by Trial Status
  • MeMed Diagnostics LTD Ongoing Clinical Trials Summary
  • Diagnostic Test - COVID-19 - Product Status
  • Diagnostic Test - COVID-19 - Product Description
  • ImmunoPoC - Product Status
  • ImmunoPoC - Product Description
  • MeMed Alert - Product Status
  • MeMed Alert - Product Description
  • MeMed BV - Product Status
  • MeMed BV - Product Description
  • MeMed BV - A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED with Suspicion of Acute Infection
  • MeMed BV - A Multi-center, Prospective, Validation Study to Assess the Accuracy of a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Adult Patients with Lower Respiratory Tract Infections
  • MeMed BV - Field Study of Host-based Immunoassay for Differentiating Bacterial From Viral Infections (Post-marketing Study of ImmunoXpert)
  • MeMed COVID-19 Severity Test - Product Status
  • MeMed COVID-19 Severity Test - Product Description
  • MeMed ImmnuoRNA - Product Status
  • MeMed ImmnuoRNA - Product Description
  • MeMed Neo - Product Status
  • MeMed Neo - Product Description
  • MeMed Sepsis - Product Status
  • MeMed Sepsis - Product Description
  • MeMed Ultra Flu - Product Status
  • MeMed Ultra Flu - Product Description
  • Prognostic Test - COVID-19 - Product Status
  • Prognostic Test - COVID-19 - Product Description
MeMed Diagnostics Ltd, Key Employees
  • Glossary
List of Figures
  • MeMed Diagnostics LTD Pipeline Products by Equipment Type
  • MeMed Diagnostics LTD Pipeline Products by Development Stage
  • MeMed Diagnostics LTD Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Trima Pharmaceutical Products Maabarot Ltd
  • Perrigo Israel Pharmaceuticals Ltd
  • JPMed Ltd
Note: Product cover images may vary from those shown
Adroll
adroll